Can amniotic fluid be an alternative organ preservation solution for cold renal storage?

  • Başak Büyük Department of Histology and Embryology, Faculty of Medicine, İzmir Democracy University, İzmir, Turquía
  • Tuba Demirci Department of Histology and Embryology, Faculty of Medicine, Atatürk University, Erzurum, Turquía
  • Yasemen Adalı Department of Pathology, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale, Turquía
  • Hüseyin Avni Eroğlu Department of Physiology, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale, Turquía
Keywords: amniotic fluid; cold ischemia; Wistar rats; organ preservation; renal transplantation

Abstract

Introduction: Kidney-transplantation is a life-saving treatment option for patients with chronic renal failure. Preserving the viability of the organ from the removal of the organ until transplantation into the recipient is one of the most essential factors affecting postransplant success. Kidney tissue is exposed to ischemia following removal of the organ from the donor, initiating some cellular events. Amniotic fluid (AF) was previously reported as a preservation solution for the liver, but not for the kidney yet. The aim of this study is to investigate the effectiveness of AF as a preserving solution for rat kidneys compared with the University of Wisconsin (UW) and Histidine-Tryptophan-Ketoglutarate (HTK), which are reported to be the most commonly used and preferred preserving solutions. Methods: Forty male Wistar albino rats were used in this study in four experimental groups. Group 1: Ringer Lactate (RL, Control) group, Group 2: HTK group, Group 3: UW group, and Group 4: AF group. A midline incision was performed, and the renal artery was isolated under ketamine and xylazine anesthesia. Solutions relevant for groups (cooled to + 4°C) were used for kidney perfusion. Nephrectomy was applied, and the removed kidneys were placed into + 4°C standard organ storage solution and stored at + 4° C for 12 hours. After 12 hours of storage, samples from the kidney tissues were fixed in 10% neutral buffered formalin. Histopathological, immunohistochemistry evaluation and apoptosis detection via TUNEL method were performed. Results: The results of the AF group were close to those of the UW and HTK groups. Tubular necrosis and vacuolization were high in the RL solution group when compared to the other ‎experimental groups. Immunohistochemistry staining for all three markers (TNF-alpha, IL-18, and iNOS) was decreased in the amniotic fluid group, similar to the UW and HTK groups. Also, the number of apoptotic cells was decreased in the AF group compared to control. Conclusions: UW, HTK, and AF had similar and higher protective effects compared to the RL solution. Thus, AF may be used as an inexpensive and readily available alternative natural tissue preservation solution.

References

1) McAnulty JF, Reid TW, Waller KR, Murphy CJ. Successful six-day kidney preservation using trophic factor supplemented media and simple cold storage. Am J Transplant. 2002;2(8):712-8.

2) Mahendran AO, Barlow AD. Kidney transplantation. Surgery (Oxford). 2014;32(7):364-70.

3) Wang S, Gumpper K, Tan T, Luo X, Guo H, Ming C, et al. A novel organ preservation solution with efficient clearance of red blood cells improves kidney transplantation in a canine model. Cell Biosci. 2018;8(1):28.

4) Marcén R, Burgos FJ, Ocaña J, Pascual J, Perez-Sanz P, Galeano C, et al. Wisconsin and Celsior solutions in renal preservation: a comparative preliminary study. Transplant Proc. 2005;37(3):1419-20.

5) Büyük B, Karakoç E. Effects of thiopental in cold ischemia in liver transplantation: An experimental study. J Surg Med. 2019;3(1):143-8.

6) Turhan-Haktanır N, Dilek FH, Köken G, Demir Y, Yılmaz G. Evaluation of amniotic fluid as a skin graft storage media compared with RPMI and saline. Burns. 2011;37(4):652-5.

7) Sterne GD, Titley OG, Christie JL. A qualitative histological assessment of various storage conditions on short term preservation of human split skin grafts. Br J Plast Surg. 2000;53(4):331-6.

8) Büyük B, Demirci T, Adalı Y, Eroğlu HA. A new organ preservation solution for static cold storage of the liver. Amniotic fluid. Acta Cir Bras. 2019;34(4):e201900402.

9) Estados Unidos. National Research Council. Guide for the Care and Use of Laboratory Animals [Internet]. 8th ed. Washington, DC: The National Academies Press, 2011. Disponible en: https://www.nap.edu/catalog/12910/guide-for-the-care-and-use-of-laboratory-animals-eighth (Consulta: 10/08/2019).

10) Akbulut S, Sevmis S, Karakayali H, Bayraktar N, Unlukaplan M, Oksuz E, et al. Amifostine enhances the antioxidant and hepatoprotective effects of UW and HTK preservation solutions. World J Gastroenterol. 2014;20(34):12292-300.

11) Janssen H, Janssen PH, Broelsch CE. UW is superior to Celsior and HTK in the protection of human liver endothelial cells against preservation injury. Liver Transpl. 2004;10(12):1514-23.

12) Wang L, Wei J, Jiang S, Li HH, Fu L, Zhang J, et al. Effects of different storage solutions on renal ischemia tolerance after kidney transplantation in mice. Am J Physiol Renal Physiol. 2018;314(3):F381-7.

13) Parsons RF, Guarrera J V. Preservation solutions for static cold storage of abdominal allografts: Which is best? Curr Opin Organ Transplant. 2014;19(2):100-7.

14) Nunes P, Mota A, Figueiredo A, Macário F, Rolo F, Dias V, et al. Efficacy of renal preservation: comparative study of Celsior and University of Wisconsin solutions. Transplant Proc. 2007;39(8):2478-9.

15) Agarwal A, Goggins WC, Pescovitz MD, Milgrom ML, Murdock P, Fridell JA. Comparison of histidine-tryptophan ketoglutarate and University of Wisconsin solutions as primary preservation in renal allografts undergoing pulsatile perfusion. Transplant Proc. 2005;37(5):2016-9.

16) Caban A, Dolińska B, Budziński G, Oczkowicz G, Ostróżka-Cieślik A, Cierpka L, et al. The effect of HTK solution modification by addition of thyrotropin and corticotropin on biochemical indices reflecting ischemic damage to porcine kidney. Transplant Proc. 2013;45(5):1720-2.

17) Bessems M, Doorschodt BM, Albers PS, van Vliet AK, van Gulik TM. Wash-out of the non-heart-beating donor liver: a comparison between ringer lactate, HTK, and polysol. Transplant Proc. 2005;37(1):395-8.

18) Mangus RS, Fridell JA, Vianna RM, Milgrom MA, Chestovich P, Chihara RK, et al. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in extended criteria liver donors. Liver Transpl. 2008;14(3):365-73.

19) Schreinemachers MC, Doorschodt BM, Florquin S, Tolba RH. Comparison of preservation solutions for washout of kidney grafts: an experimental study. Transplant Proc. 2009;41(10):4072-9.

20) Li S, Constantinescu I, Guan Q, Kalathottukaren MT, Brooks DE, Nguan CY, et al. Advantages of replacing hydroxyethyl starch in University of Wisconsin solution with hyperbranched polyglycerol for cold kidney perfusion. J Surg Res. 2016;205(1):59-69.

21) Singh M, Odeniyi DT, Apostolov EO, Savenka A, Fite T, Wangila GW, et al. Protective effect of zinc-N-acetylcysteine on the rat kidney during cold storage. Am J Physiol Physiol Renal Physiol. 2013;305(7):1022-30.

22) Moen J, Claesson K, Pienaar H, Lindell S, Ploeg RJ, McAnulty JF, et al. Preservation of dog liver, kidney, and pancreas using the Belzer-UW solution with a high-sodium and low-potassium content. Transplantation. 1989;47(6):940-5.

23) Ramella SG, Hadj-Aïssa A, Barbieux A, Steghens JP, Colpart JJ, Zech P, et al. Evaluation of a high sodium-low potassium cold-storage solution by the isolated perfused rat kidney technique. Nephrol Dial Transplant. 1995;10(6):842-6.

24) Thomasen H, Pauklin M, Noelle B, Geerling G, Vetter J, Steven P, et al. The effect of long-term storage on the biological and histological properties of cryopreserved amniotic membrane. Curr Eye Res. 2011;36(3):247-55.

25) Turhan-Haktanir N, Sahin Ö, Yagmurca M, Köken G, Demir Y, Cosar E. Histological assessment of skin grafts stored in amniotic fluid and saline. J Plast Surg Hand Surg. 2010;44(4):226-30.

26) Qi QA, Yang ZY, Ma KS, Lu Q, Wang SG, Li XW, et al. Impact of cold ischemia on cytokines after partial liver transplantation in rats. Gen Molec Res. 2013;12(3):4003-8.

27) Zhang H, Hile KL, Asanuma H, Vanderbrink V, Franke EI, Campbell MT, et al. IL-18 mediates proapoptotic signaling in renal tubuler cells through a Fas ligand-dependent mechanism. Am J Physiol Renal Physiol. 2011;301(1):171-8.

28) Matsui F, Rhee A, Hile KL, Zhang H, Meldrum KK. IL-18 induces profibrotic renal tubular cell injury via STAT3 activation. Am J Physiol Renal Physiol. 2013;305(7):F1014-F1021.

29) Parikh CR, Jani A, Mishra J, Ma Q, Kelly C, Barasch J, et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant. 2006 Jul;6(7):1639-45.

30) Meguro M, Katsuramaki T, Nagayama M, Kimura H, Isobe M, Kimura Y, et al. A novel inhibitor of inducible nitric oxide synthase (ONO-1714) prevents critical warm ischemia-reperfusion injury in the pig liver. Transplantation. 2002;73(9):1439-46.
Published
2020-08-26
How to Cite
1.
Büyük B, Demirci T, Adalı Y, Eroğlu HA. Can amniotic fluid be an alternative organ preservation solution for cold renal storage?. Rev Nefrol Dial Traspl. [Internet]. 2020Aug.26 [cited 2024Aug.14];40(1):14-. Available from: http://revistarenal.org.ar/index.php/rndt/article/view/504
Section
Original Article